Ultrastructure of a Carbon Nanotube-based Delivery System for Cancer Therapy

用于癌症治疗的碳纳米管输送系统的超微结构

基本信息

项目摘要

Carbon nanotubes with attached drugs and directing ligands have excellent potential for targeted drug delivery. Single wall carbon nanotubes (SWNT) with very high specific surface areas can be derivatized with biomolecules either through chemical attachment, adsorption or encapsulation. Such bioconjugates on SWNTs have the ability to deliver bioactive molecules across cell membranes and even into cell nuclei. We have performed ultrastructural experiments to investigate the application of functionalized carbon nanotubes to deliver therapeutic drugs to oral cancer cells. The anti-cancer drug cisplatin was covalently bound to single walled carbon nanotubes (SWNTs) and these were in turn bound to epidermal growth factor (EGF), which is expressed at very high levels by oral cancer cells. Cultured head and neck squamous cell carcinoma (HNSCC) cells of epithelial origin incubated with the functionalized nanoparticles were prepared for electron microscopy by fixation in glutaraldehyde and osmium tetroxide, followed by dehydration and embedding in epon. Electron micrographs, recorded digitally using a 120 kV TEM, revealed that bundles of SWNTs had entered the cells. In most HNSCC cells the SWNT bundles were distributed throughout the cytoplasm, whereas some cells showed a higher concentration of nanotubes adjacent to the cell nucleus. The results confirmed lower resolution data obtained from confocal fluorescence microscopy but provided more detailed information about the subcellular structures associated with the nanotubes after entry. The ultrastructural data are being correlated with optical measurements and cell viability assays conducted in NIDCR. We have also used scanning transmission electron microscopy (STEM) and x-ray nanoanalysis to characterize individual nanotubes and to determine the distribution of bound platinum atoms. Characterization of these nanoparticle bioconjugates is essential for the future progress of this approach. In particular, nanotube size, and number of biomolecules per nanotube length are important parameters, especially for drug delivery. Our STEM results show for the first atomic scale visualization and quantification of single Pt-based drug molecules attached to SWNTs.
带有药物和导向配体的碳纳米管具有很好的靶向药物传递的潜力。单壁碳纳米管(SWNT)具有很高的比表面积,可以通过化学附着、吸附或包埋的方式与生物分子进行衍生化。这种单壁碳纳米管上的生物偶联物具有将生物活性分子穿过细胞膜甚至进入细胞核的能力。我们进行了超微结构实验,以研究功能化碳纳米管在口腔癌细胞中的应用。抗癌药物顺铂被共价结合到单壁碳纳米管(SWNTs)上,这些单壁碳纳米管又与口腔癌细胞高水平表达的表皮生长因子(EGF)结合。将功能化纳米颗粒与培养的头颈部鳞状细胞癌(HNSCC)细胞孵育后,用戊二醛和四氧化三铯固定,脱水包埋在EPON中,制备电子显微镜。使用120千伏电子显微镜数字化记录的电子显微镜显示,成束的单壁碳纳米管已经进入细胞。在大多数HNSCC细胞中,SWNT束分布在细胞质中,而一些细胞在细胞核附近显示出较高浓度的纳米管。结果证实了从共聚焦荧光显微镜获得的较低分辨率的数据,但提供了关于进入纳米管后与亚细胞结构相关的更详细的信息。超微结构数据与NIDCR进行的光学测量和细胞存活率分析相关联。我们还使用扫描电子显微镜(STEM)和X射线纳米分析来表征单个纳米管,并确定结合的铂原子的分布。这些纳米颗粒生物偶联物的表征对于这一方法的未来进展是至关重要的。特别是,纳米管的大小和每根纳米管的生物分子数是重要的参数,特别是对于药物输送而言。我们的STEM结果首次显示了单个铂基药物分子附着在单壁碳纳米管上的原子尺度可视化和量化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard Leapman其他文献

Richard Leapman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard Leapman', 18)}}的其他基金

Ultrastructure of a Carbon Nanotube-based Delivery System for Cancer Therapy
用于癌症治疗的碳纳米管输送系统的超微结构
  • 批准号:
    8340620
  • 财政年份:
  • 资助金额:
    $ 3.16万
  • 项目类别:
Intramural Training of NIH Biomedical Imaging and Bioengineering Researchers
NIH 生物医学成像和生物工程研究人员的校内培训
  • 批准号:
    8340644
  • 财政年份:
  • 资助金额:
    $ 3.16万
  • 项目类别:
Structure Of Beta Amyloid Fibrils
β淀粉样原纤维的结构
  • 批准号:
    7967868
  • 财政年份:
  • 资助金额:
    $ 3.16万
  • 项目类别:
Platinum Accumulation in Pigmented Granules of Cisplatin-Treated Melanoma Cells
顺铂处理的黑色素瘤细胞色素颗粒中铂的积累
  • 批准号:
    7967892
  • 财政年份:
  • 资助金额:
    $ 3.16万
  • 项目类别:
Mass Mapping of Macromolecular Assemblies
大分子组装体的质量作图
  • 批准号:
    8743765
  • 财政年份:
  • 资助金额:
    $ 3.16万
  • 项目类别:
Energy-Filtered Electron Tomography
能量过滤电子断层扫描
  • 批准号:
    8743771
  • 财政年份:
  • 资助金额:
    $ 3.16万
  • 项目类别:
Development of Conjugated Gold Clusters for Studies on Cellular Internalization
用于细胞内化研究的共轭金簇的开发
  • 批准号:
    8933888
  • 财政年份:
  • 资助金额:
    $ 3.16万
  • 项目类别:
Electron microscopy of therapeutic and diagnostic nanoparticles
治疗和诊断纳米颗粒的电子显微镜
  • 批准号:
    9152063
  • 财政年份:
  • 资助金额:
    $ 3.16万
  • 项目类别:
Infrastructure for Trans-NIH Imaging Initiative: Imaging from Molecules to Cells
跨 NIH 成像计划的基础设施:从分子到细胞的成像
  • 批准号:
    7734396
  • 财政年份:
  • 资助金额:
    $ 3.16万
  • 项目类别:
Energy-Filtered Electron Microscopy and Electron Spectroscopic Imaging
能量过滤电子显微镜和电子光谱成像
  • 批准号:
    10011332
  • 财政年份:
  • 资助金额:
    $ 3.16万
  • 项目类别:

相似海外基金

Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
  • 批准号:
    9975367
  • 财政年份:
    2020
  • 资助金额:
    $ 3.16万
  • 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
  • 批准号:
    16K11932
  • 财政年份:
    2016
  • 资助金额:
    $ 3.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
  • 批准号:
    19591274
  • 财政年份:
    2007
  • 资助金额:
    $ 3.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
  • 批准号:
    6346309
  • 财政年份:
    2000
  • 资助金额:
    $ 3.16万
  • 项目类别:
TRAINING IN PHARMACOLOGY OF ANTINEOPLASTIC AGENTS
抗肿瘤药物药理学培训
  • 批准号:
    2720213
  • 财政年份:
    1999
  • 资助金额:
    $ 3.16万
  • 项目类别:
TRAINING IN PHARMACOLOGY OF ANTINEOPLASTIC AGENTS
抗肿瘤药物药理学培训
  • 批准号:
    6513197
  • 财政年份:
    1999
  • 资助金额:
    $ 3.16万
  • 项目类别:
Training in Pharmacology of Antineoplastic Agents
抗肿瘤药物药理学培训
  • 批准号:
    7101017
  • 财政年份:
    1999
  • 资助金额:
    $ 3.16万
  • 项目类别:
Training in Pharmacology of Antineoplastic Agents
抗肿瘤药物药理学培训
  • 批准号:
    6894842
  • 财政年份:
    1999
  • 资助金额:
    $ 3.16万
  • 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
  • 批准号:
    2885074
  • 财政年份:
    1999
  • 资助金额:
    $ 3.16万
  • 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
  • 批准号:
    6174221
  • 财政年份:
    1999
  • 资助金额:
    $ 3.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了